ArticleInternational journal of molecular sciences2026
Isolation and Molecular Characterization of Emerging Getah Virus Genotype III Variant Strains from Swine in Southeastern China (2024-2025).
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
As a member of the Alphavirus genus, Getah virus (GETV) has become an emerging pathogen posing severe threats to animal health and public health security. In recent years, GETV has caused increasing outbreaks in swine herds, leading to substantial economic losses in the pig industry in China. Here, we report continuous GETV outbreaks on pig farms across southeastern China between September 2024 and December 2025. A total of 185 clinical samples were examined, among which 27 were positive (14.6%). Subsequently, five GETV strains were successfully isolated and subjected to whole-genome sequencing. Phylogenetic analysis revealed that all the 5 isolated strains belonged to genotype III(GIII), with two strains (GETV-AHX2024 and GETV-JS2024) forming a distinct GIII variant clade. Notably, multiple specific amino acid mutations were identified in the nsp3, C, E2, 6K, and E1 proteins and 3'UTR of these GIII variant strains. Pathogenicity in mice revealed that mice infected with the GIII variant strain GETV-JS2024 exhibited a longer viral shedding period compared with other strains. These findings highlight the emergence of GETV GIII variant strains in southeastern China and suggest their altered pathogenic performance in mice. These results supplied critical data for molecular surveillance and subsequent pathogenic analysis of GETV in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.